Current Trends in Cancer Pain Management

Cancer Pain

Volumn , Issue , 2006, Pages 13-23

  Esphani, Naznin ^a   Bruera, Eduardo ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872085725     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-7216-0261-5.50007-7     Document Type: Chapter

References (115)

1. Larue F, Colleau SM, Breasseur L, et al. Multicenter study of cancer pain and its treatment in France. Br Med J 1995, 310:1034-1037.
2. Bonica JJ, Ventafridda V, Twycross RG Cancer Pain. The Management of Pain 1990, vol 1:400-460. Lea & Febiger, Philadelphia. 2nd ed. J.J. Bonica (Ed.).
3. Jacox A, Carr DB, Payne R, et al: Management of cancer pain. Clinical Practice Guideline No 9. AHCPR Publication N. 94-0592. Rockville, Md. Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Service; March 1994, 8.
4. Sela RA, Bruera E, Conner-Spady B, et al. Sensory and affective dimensions of advanced cancer pain. Psycho-Oncology 2002, 11:23-34.
5. Westwell P, Johnson NF A comparison of pain vocabulary and affective symptoms in patients with malignant and non malignant disorders. Med Sci Res 1988, 16:583-584.
6. Wagner G Frequency of pain in patients with cancer. Recent Results in Cancer Res 1984, 89:64-71.
7. World Health Organization National Cancer Control Programmes: Policies and Managerial Guideline 2002, World Health Organization, Geneva. 2nd ed.
8. Folkman S, Lazarus RS, Dunkel-Schetter C, et al. Dynamics of a stressful encounter: Cognitive appraisal, coping, and encounter outcomes. J Pers Soc Psychol 1986, 50:992-1003.
9. Fishman B The cognitive behavioral perspective on pain management in terminal illness. Hosp J 1992, 8:73-88.
10. Syrjala KL, Chapko ME Evidence for a biopsychosocial model of cancer treatment-related pain. Pain 1995, 61:69-79.
11. Massie MJ, Holland JC The cancer patient with pain: Psychiatric complications and their management. J Pain Symptom Manage 1992, 7:99-109.
12. Feuz A, Rapin CH An observational study of the role of pain control and food adaptation of elderly patients with terminal cancer. J Am Diet Assoc 1994, 94:767-770.
13. Ferrell BR The impact of pain on quality of life: A decade of research. Nurs Clin North Am 1995, 30:609-624.
14. Burrows M, Dibble SL, Miaskowski C Differences in outcomes among patients experiencing different types of cancer-related pain. Oncol Nurs Forum 1998, 25:735-741.
15. Thorpe DM. The incidence of sleep disturbance in cancer patients with pain. In 7th World Congress on Pain: Abstracts. IASP Publications, Seattle, Abstract 451, 1993.
16. Cleeland CS, Nakamura Y, Mendoza TR, et al. Dimensions of the impact of cancer pain in a four country sample: new information from multidimensional scaling. Pain 1996, 67:267-273.
17. Barkwell DP Ascribed meaning: A critical factor in coping and pain attenuation in patients with cancer-related pain. J Palliat Care 1991, 7:5-14.
18. Bond MR, Pearson IB Psychological aspects of pain in women with advanced cancer of the cervix. J Psychosom Res 1969, 13:13-19.
19. Ventafridda V Continuing care: A major issue in cancer pain management. Pain 1989, 36:137-143.
20. Shegda LM, McCorkle R Continuing care in the community. J Pain Symptom Manage 1990, 5:279-286.
21. Muir CJ, McDonagh A, Gooding N Multidimensional patient assessment. Principles and Practice of Palliative Care & Supportive Oncology 2002, 651-660. Lippincott Williams & Wilkins, Philadelphia. 2nd ed. A. Berger, R.K. Portenoy, D.E. Weissman (Eds.).
22. McHugh M, West P, Assatly C, et al. Establishing an interdisciplinary patient care team: Collaboration at the bedside and beyond. J Nurs Adm; 1996, 26:21-27.
23. Massie MJ, Holland J, Glass E. Delirium in terminally ill cancer patients. Am J Psychiatry 1983, 140:1048-1050.
24. Lawlor PG, Bruera E Delirium in patients with advanced cancer. Hematol Oncol Clin North Am 2002, 16:701-714.
25. Lipowski ZJ Delirium (acute confusional states). JAMA 1987, 285:1789-1792.
26. Gillick MR, Serrel NA, Gillick LS Adverse consequences of hospitalization in the elderly. Soc Sci Med 1982, 16:1033-1038.
27. Bruera E, Miller MJ, McCallion J, et al. Cognitive failure in patients with terminal cancer: A prospective study. J Pain Symptom Manage 1992, 7:192-195.
28. Bruera E, Kuehn N, Miller MJ, et al. The Edmonton Symptom Assessment System (ESAS): A simple method for the assessment of palliative care patients. J Palliat Care 1991, 7:6-9.
29. Williams MA Delirium/acute confusional states: Evaluation devices in nursing. Int Psychogeriatr 1991, 3:301-308.
30. Breitbart W, Rosenfeld B, Roth A, et al. The Memorial Delirium Assessment Scale. J Pain Symptom Manage 1997, 13:128-137.
31. Daut RL, Cleeland CS, Flannery RC Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases. Pain 1983, 17:197-210.
32. Melzack R The McGill pain questionnaire. Pain Measurement and Assessment 1983, 41-48. Raven, New York. R. Melzack (Ed.).
33. Breitbart W, Marotta R, Platt M, et al. A double-blind trial of haloperidol, chlor-promazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients. Am J Psychiatr 1996, 153:231-237.
34. Lawlor PG, Gagnon B, Mancini IL, et al. Occurrence, causes, and outcome of delirium in advanced cancer patients: A prospective study. Arch Intern Med 2000, 160:786-794.
35. Breitbart W, Passik S Psychiatric aspects of palliative care. Oxford Textbook of Palliative Medicine 1998, 933-954. Oxford University Press, Oxford. 2nd ed. D. Doyle, G.W.C. Hanks, N. MacDonald (Eds.).
36. Bruera E, Pereira J Neuropsychiatric toxicity of opioids. Proceedings of the 8th World Congress on Pain 1996, 717-738. IASP Press, Seattle. T.S. Jensen, J.A. Turner, Z. Wiesenfeld-Hallin (Eds.).
37. Fainsinger R, MacEachern T, Hanson J, et al. Symptom control during the last week of life in a palliative care unit. J Palliat Care 1991, 7:5-11.
38. Leipzig R, Goodman H, Gray G, et al. Reversible narcotic associated mental status impairment in patients with metastatic cancer. Pharmacology 1987, 35:47-54.
39. Bruera E, Fainsinger R, Miller MJ, Kuehn N The assessment of pain intensity in patients with cognitive failure: A preliminary report. J Pain Symptom Manage 1992, 7:267-270.
40. Levine PM, Silverfarb PM, Lipowski ZJ Mental disorders in cancer patients: A study of 100 psychiatric referrals. Cancer 1978, 42:1385-1391.
41. Trzepacz PT, Teague GB, Lipowski ZJ Delirium and other organic mental disorders in a general hospital. Gen Hosp Psychiatry 1985, 7:101-106.
42. Inouye SK, Van Dyck CH, Alessi CA Clarifying confusion: The Confusion Assessment method. Ann Intern Med 1990, 113:941-948.
43. Daeninck PJ, Bruera E Opioid use in cancer pain: Is a more liberal approach enhancing toxicity?. Acta Anesthesiol Scand 1999, 43(9):924-938.
44. Bruera E, Macmillan K, Hanson J, et al. The cognitive effects of the administration of narcotic analgesics in patients with cancer pain. Pain 1989, 39:13-16.
45. Posner JB Delirium and exogenous metabolic brain disease. Cecil Textbook of Medicine 1979, 644-651. Saunders, Philadelphia. P.B. Beeson, W. McDermott, J.B. Wyngarden (Eds.).
46. Cherny N, Ripamonti C, Pereira J, et al. Strategies to manage the adverse effects of oral morphine: An evidence-based report. J Clin Oncol 2001, 19:2542-2554.
47. Silberfarb PM Chemotherapy and cognitive defects in cancer patients. Annu Rev Med 1983, 34:35-46.
48. Stiefel F, Breitbart WS, Holland JC Corti-costeroids in cancer: Neuropsychiatric complications. Cancer Invest 1989, 7:479-491.
49. Stiefel F, Fainsinger R, Bruera E Acute confusional states in patients with advanced cancer. J Pain Symptom Manage 1992, 7:94-98.
50. Stiefel F, Holland J Delirium in cancer patients. Int Psychogeriatr 1991, 3:333-336.
51. Gagnon B, Lawlor PG, Mancini IL, et al. The impact of delirium on the circadian distribution of breakthrough analgesia in advanced cancer patients. J Pain Symptom Manage 2001, 22:826-833.
52. Wise MG, Brandt GT Delirium. Textbook of Neuropsychiatry 1992, 363-423. American Psychiatric Press, Washington, DC. 2nd ed. S.C. Yudofsky, R.E. Hales (Eds.).
53. Ross CA CNS arousal systems: Possible role in delirium. Int Psychogeriatr 1991, 3:353-371.
54. Bruera E, Schoeller T, Wenk R, et al. A prospective multi-center assessment of the Edmonton Staging System for cancer pain. J Pain Symptom Manage 1995, 10:348-355.
55. Pereira J, Bruera E Chronic nausea. Cachexia-Anorexia in Cancer Patients 1996, 23-37. Oxford University Press, New York. E. Bruera, I. Higginson (Eds.).
56. Vigano A, Watanabe S, Bruera E Anorexia and cachexia in advanced cancer patients. Cancer Surv 1994, 21:99-115.
57. MacDonald N, Alexander R, Bruera E Cachexia-anorexia-asthenia. J Pain Symptom Manage 1995, 10:151-155.
58. Bruera E, Fainsinger R Clinical management of cachexia and anorexia. Oxford Textbook of Palliative Medicine 1998, Oxford University Press, Oxford. 2nd ed. D. Doyle, G. Hanks, N. MacDonald (Eds.).
59. Breitbart W Diagnosis and management of delirium in the terminally ill. Topics in Palliative Care 2001, vol 5:303-321. Oxford University Press, Oxford. E. Bruera, R.K. Portenoy (Eds.).
60. Fainsinger RL, Tapper M, Bruera E A perspective on the management of delirium in terminally ill patients on a palliative care unit. J Palliat Care 1993, 9:4-8.
61. Lawlor PG Delirium. Handbook of Advanced Cancer Care 2003, 390-396. Cambridge University Press, Cambridge. 1st ed. M.J. Fisch, E. Bruera (Eds.).
62. Lawlor PG, Bruera E. Side effects of opioids in chronic pain treatment. Curr Opin Anaesthesiol 1998, 11:539-545.
63. d' Stoutz ND, Bruera E, Suarez-Almazor M. Opioid rotation for toxicity in terminal cancer patients. J Pain Symptom Manage 1995, 10:5-378.
64. Tuma R, DeAnngelis LM Altered mental status in patients with cancer. Arch Neurol 2000, 57:1727-1731.
65. Breitbart W Psychiatric complications of cancer. Current Therapy in Hematology Oncology 1988, 268-274. B.C. Decker Inc, Toronto and Philadelphia. 3rd ed. M.C. Brain, P.P. Carbone (Eds.).
66. Sipahimalani A, Massand PS Olanzapine in the treatment of delirium. Psychosomatics 1998, 39:422-430.
67. Sipahimalani A, Sime RM, Massand PS Treatment of delirium with risperidone. Int J Geriatr Psychopharmacol 1997, 1:24-26.
68. Bruera E, Moyano J, Seifert L, Fainsinger RL, Hanson J, Suarez-Almazor M The frequency of alcoholism among patients with pain due to terminal cancer. J Pain Symptom Manage 1995, 10:599-603.
69. Ewing J Detecting alcoholism: The CAGE questionnaire. JAMA 1984, 252:1905-1907.
70. Mansky P Reminiscence of an addictionalogist: Thoughts of a researcher and clinician. Psychiatr Q 1993, 64:81-106.
71. Franklin JE, Frances RJ Alcohol and other psychoactive substance disorders. Text book of Psychiatry 1999, 363-423. The American Psychiatry Press Inc., Washington, DC. 3rd ed. R.E. Hales, S.C. Yudofsky, J.A. Talbott (Eds.).
72. Kessler RC, Crumb, Warner LA, et al. Lifetime ccO-occurrence of DSM-111 R alcohol abuse and dependence with other psychiatric disorders in the national comorbidity survey. Arch Gen Psychiatry 1997, 54:313-321.
73. Skykes J, Johnson R, Hanks GW Difficult pain problems. Br Med J 1997, 315:867-869.
74. Hwang SS, Chang VT, Fairclough DL, et al. Development of cancer pain prognostic scale. J Pain Symptom Manage 2002, 24(4):366-378.
75. Lichter I Nausea and vomiting in patients with cancer. Hematol Oncol Clin North Am 1996, 10:207-220.
76. Gamsa A Is emotional disturbance a precipitator or a consequence of chronic pain. Pain 1990, 42:183-195.
77. Massie MJ, Holland JC The cancer patient with pain: Psychiatric complications and their management. J Pain Symptom Manage 1992, 7:99-109.
78. Ferrell BR The impact of pain on quality of life: A decade of research. Nurs Clin North Am 1995, 30:609-624.
79. Stone P, Richards M, Hardy J Fatigue in patients with cancer. Eur J Cancer 1998, 34(11):1670-1676.
80. Cella D, Peterman A, Passik S, et al. Progress toward guidelines for the management of fatigue. Oncology 1998, 12(11A):369-377.
81. Portenoy RK, Itri LM Cancer-related fatigue: Guidelines for evaluation and management. Oncologist 1999, 4(1):1-10.
82. Cherny NI, Catane R Professional negligence in the management of cancer pain: A case for urgent reforms [editorial; comment]. Cancer 1995, 76:2181-2185.
83. Edwards RB Pain management and the values of health care providers. Drug Treatment of Cancer Pain in a Drug Oriented Society: Advances in Pain Research and Therapy 1989, vol 11:101-112. Raven, New York. C.S. Hill, W.S. Fields (Eds.).
84. Emanuel EJ Pain and symptom control: Patient rights and physician responsibilities. Hematol Oncol Clin North Am 1996, 10(1):41-56.
85. Haugen PS Pain relief. Legal aspects of pain relief for the dying. Minn Med 1997, 80:15-18.
86. Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994, 330:592-596.
87. Grossman SA, Sheidler VR, Swedeen K, et al. Correlation of patient and caregiver ratings of cancer pain. J Pain Symptom Manage 1991, 6:53-57.
88. Von Roenn JH, Cleeland CS, Gonin R, et al. Physician attitudes and practice in cancer pain management. A survey from the Eastern Cooperative Oncology Group. Ann Intern Med 1993, 119(2):121-126.
89. Cherny NI, Ho MN, Bookbinder M, et al: Cancer pain: Knowledge and attitudes of physicians at a cancer center (meeting abstract). Proceedings of the Annual Meeting of the American Society of Clinical Oncologists 13, 1994.
90. Sapir R, Catane R, Cherny NI: Cancer pain: Knowledge and attitudes of physicians in Israel (meeting abstract). Proceedings of the Annual Meeting of the American Society of Clinical Oncologists 16, 1997.
91. Wade JB, Price DD, Hamer RM, et al. An emotional component analysis of chronic pain. Pain 1990, 40:303-310.
92. Fernandez E, Turk DC The scope and significance of anger in the experience of chronic pain. Pain 1995, 61:165-175.
93. Kerns RD, Rosenberg R, Jacob MC Anger expression and chronic pain. J Behavioral Med 1994, 17:57-70.
94. Jensen MP Validity of self-report and observation measures 1997, 637-661. IASP Press, Seattle, Proceedings of the 8th World Congress on Pain. R.S. Jensen, J.A. Turner, Z. Weisenfeld-Halleb (Eds.).
95. Osborne RJ, Joel SP, Grebinik K, et al. The pharmacokinetics of morphine and morphine glucoronides in kidney failure. Clin Pharmacol Ther 1993, 54:158-167.
96. D'Honneur G, Gilton A, Sandouk P, et al. Plasma and cerebrospinal fluid concentrations of morphine and morphine glucuronides after oral morphine: The influence of renal failure. Anaesthesiology 1994, 81:87-93.
97. Mercadante S Opioid rotation in cancer pain. Curr Rev Pain 1998, 3:131-142.
98. Bruera E, Pereira J, Watanabe S, et al. Opioid rotation in patients with cancer pain: A retrospective comparison of dose ratios between methadone, hydromor-phone, and morphine. Cancer 1996, 78:852-857.
99. Fainsinger R, Mac Eachern T, Miller M, et al. The use of hypodermoclysis for rehydration in terminally ill cancer patients. J Pain Symptom Manage 1994, 9(5):298-302.
100. Cherney NJ, Chang V, Frager G, et al. Opioid pharmacotherapy in the management of cancer pain. Cancer 1995, 76:1288-1293.
101. Mercadante S. Methadone in cancer pain. Eur J Pain 1997, 1:77-85.
102. Crews JC, Sweeney N, Denson DD Clinical efficacy of methadone in patients refractory to other Mu-opioid receptor agonist analgesics for the management of terminal cancer pain. Cancer 1993, 72:2266-2272.
103. Lawlor P, Turner K, Hanson J, et al. Dose ratio between morphine and methadone in patients with cancer pain: A retrospective study. Cancer 1998, 82:1167-1173.
104. Ripamonti C, Groff L, Brunelli C, et al. Switching from morphine to oral metha-done in treating cancer pain: What is the equianalgesic dose ratio?. J Clin Oncol 1998, 16:3216-3221.
105. Galer BS, Coyle N, Pasternak GW, et al. Individual variability in the response to different opioids: Report of five cases. Pain 1992, 49:87-91.
106. Vigano A, Fan D, Bruera E Individualized use of methadone and opioid rotation in the comprehensive management of cancer pain associated with poor prognostic indicators. Pain 1996, 67:115-119.
107. Morley JS, Makin MK Comments on Ripamonti, et al. Pain 1997, 73:14.
108. Bruera E, MacEachern T, Sachynski K, et al. Comparison of the efficacy, safety and pharmacokinetics of controlled release and immediate release metoclopramide for the management of chronic nausea in advanced cancer patients. Cancer 1994, 74(12):3204-3211.
109. Mancini I, Bruera E Constipation in advanced cancer patients. Support Care Cancer 1998, 6(4):356-364.
110. Sykes NP Constipation and diarrhea. Oxford Textbook of Palliative Medicine 1998, 513-526. Oxford University Press, Oxford. 2nd ed. D. Doyle, G.W.C. Hanks, N. MacDonald (Eds.).
111. Bruera E, Miller MJ, Macmillan K, et al. Neuropsychological effects of methyl-phenidate in patients receiving a continuous infusion of narcotics for cancer pain. Pain 1992, 48:163-166.
112. Bruera E, Driver L, Barnes E, et al. Patient controlled methylphenidate (PCM) for the management of fatigue in patients with advanced cancer. J Clin Oncol 2003, 21:4439-4443.
113. Bruera E, Strasser F, Shen L, et al. The effect of donepezil on sedation and other symptoms in patients receiving opioids for cancer pain: A pilot study. J Pain Symptom Manage 2003, 26(5):1049-1054.
114. Bruera E, Roca E, Cedaro, et al. Action of oral prednisolone sodium succinate on quality of life in preterminal cancer patients: A placebo-controlled Multi-center Study. The Methylpredinisolone Preterminal Cancer Study Group. Eur J Cancer 1989, 25:1817-1821.
115. Tannock I, Gospodarowicz M, Makin W, et al. Treatment of metastatic prostate cancer with low dose prednisone: Evaluation of pain and quality of life as prognostic indices of response. J Clin Oncol 1989, 7:590-597.